Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chizu Tanikawa

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Cancer Science|December 5, 2023
Regulation of the innate immune response and gut microbiome by p53Amy Hui Ping Khor, Tomoyuki Koguchi, Hao Liu, et al.
Cancer Science|October 20, 2007
Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesisArata Shimo, Chizu Tanikawa, Toshihiko Nishidate, et al.
Oncotarget|February 10, 2018
Decrease in <i>PSCA</i> expression caused by <i>Helicobacter pylori</i> infection may promote progression to severe gastritisOsamu Toyoshima, Chizu Tanikawa, Ryuta Yamamoto, et al.
British Journal of Cancer|June 25, 2026
Circulating tumor-associated autoantibody signatures for diagnosis and prognosis in small-cell lung cancer and lung adenocarcinomaChaoqi Liu, Eriko Fukuda, Yoji Sagiya, et al.
Ebiomedicine|June 1, 2017
The Transcriptional Landscape of p53 Signalling PathwayChizu Tanikawa, Yao-Zhong Zhang, Ryuta Yamamoto, et al.
Scientific Reports|September 8, 2017
Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cellsYusuke Tsuda, Chizu Tanikawa, Takafumi Miyamoto, et al.
Nature Genetics|November 30, 2023
East Asian-specific and cross-ancestry genome-wide meta-analyses provide mechanistic insights into peptic ulcer diseaseYunye He, Masaru Koido, Yoichi Sutoh, et al.
Cell Reports|February 10, 2018
Citrullination of RGG Motifs in FET Proteins by PAD4 Regulates Protein Aggregation and ALS SusceptibilityChizu Tanikawa, Koji Ueda, Akari Suzuki, et al.
Journal of Human Genetics|April 8, 2011
Common variants on 14q32 and 13q12 are associated with DLBCL susceptibilityVinod Kumar, Keitaro Matsuo, Atsushi Takahashi, et al.
Cancer Science|June 3, 2009
Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcomaKazuhito Morioka, Chizu Tanikawa, Kensuke Ochi, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Cancer Science|December 5, 2023
Regulation of the innate immune response and gut microbiome by p53Amy Hui Ping Khor, Tomoyuki Koguchi, Hao Liu, et al.
Cancer Science|October 20, 2007
Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesisArata Shimo, Chizu Tanikawa, Toshihiko Nishidate, et al.
Oncotarget|February 10, 2018
Decrease in <i>PSCA</i> expression caused by <i>Helicobacter pylori</i> infection may promote progression to severe gastritisOsamu Toyoshima, Chizu Tanikawa, Ryuta Yamamoto, et al.
British Journal of Cancer|June 25, 2026
Circulating tumor-associated autoantibody signatures for diagnosis and prognosis in small-cell lung cancer and lung adenocarcinomaChaoqi Liu, Eriko Fukuda, Yoji Sagiya, et al.
Ebiomedicine|June 1, 2017
The Transcriptional Landscape of p53 Signalling PathwayChizu Tanikawa, Yao-Zhong Zhang, Ryuta Yamamoto, et al.
Scientific Reports|September 8, 2017
Identification of a p53 target, CD137L, that mediates growth suppression and immune response of osteosarcoma cellsYusuke Tsuda, Chizu Tanikawa, Takafumi Miyamoto, et al.
Nature Genetics|November 30, 2023
East Asian-specific and cross-ancestry genome-wide meta-analyses provide mechanistic insights into peptic ulcer diseaseYunye He, Masaru Koido, Yoichi Sutoh, et al.
Cell Reports|February 10, 2018
Citrullination of RGG Motifs in FET Proteins by PAD4 Regulates Protein Aggregation and ALS SusceptibilityChizu Tanikawa, Koji Ueda, Akari Suzuki, et al.
Journal of Human Genetics|April 8, 2011
Common variants on 14q32 and 13q12 are associated with DLBCL susceptibilityVinod Kumar, Keitaro Matsuo, Atsushi Takahashi, et al.
Cancer Science|June 3, 2009
Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcomaKazuhito Morioka, Chizu Tanikawa, Kensuke Ochi, et al.
Pageof 7